M2-macroglobulin and pregnancy-associated globulin in renal disease accompanied by proteinuria but normal levels are found in renal disease without proteinuria. Compared with normal pregnancy, (X2-macroglobulin is significantly raised in preeclampsia with proteinuria but normal in preeclampsia without proteinuria. In contrast, serum pregnancy-associated globulin is significantly reduced in preeclampsia both with and without proteinuria when compared with normal pregnancy. Maclaren, Kelleher, and Reid (1961) have described in pregnancy a serum C2-globulin, now known to be a macroglobulin (Maclaren and Alper, 1970) , and have referred to it as 'pregnancy-associated globulin' (PAG). However, it has also been found in the serum of a small number (180) of normal males and females (Maclaren, Reid, Konugres, and Allen, 1966) . Since conventional serum OC2-macroglobulin is known to be increased in the nephrotic syndrome (Schultze and Schwick, 1959; Steines and Mehl, 1966; Housley, 1968) and in preeclampsia accompanied by proteinuria (Horne, Howie, and Goudie, 1970a) , it seemed likely that the serum levels of this other macroglobulin, PAG, might also increase in such diseases. Using a radial immunodiffusion technique we have determined the serum levels of oC2-macroglobulin and PAG in 53 patients with various renal diseases and in agesex-matched controls, and also in preeclampsia with or without proteinuria and in normal pregnant controls.
Subjects and Methods
Sera were obtained from 53 patients (37 males, 16 females, mean age 34, range 13-64) who had a variety of acute and chronic renal diseases, usually some form of glomerulonephritis (Table I) Sera were also obtained from 37 preeclamptic patients (mean age 27 6 years, range 18-41, duration of pregnancy 37-1 weeks, range 30-41), 13 with proteinuria and 24 without pioteinuria, and from 37 normal pregnant controls (mean age 27-5 years, range 18-41, duration of pregnancy 37-3 weeks, range 30-41) matched for age, parity, and duration of pregnancy. Most of the pregnant patients had been included in a previous study (Home et al, 1 970a) .
Proteinuria was estimated in the renal disease patients by the Biuret method and in the preeclamptic patients by the Esbach technique.
All sera were stored at -20°C for up to two years before assay. Antiserum to PAG was prepared in rabbits by immunizing them with pregnant human serum, known to contain appreciable quantities of this protein, in Freund's complete adjuvant and absorbing the resultant antiserum with human serum which did not contain this pro-590
Serum o-macroglobulins in renal disease and preeclampsia tein (Maclaren et al, 1966) . Antiserum to serum c2-macroglobulin was prepared by the method of Goudie, Hoine, and Wilkinson (1966) .
Assay of serum cx2-macroglobulin and PAG was carried out using a radial immunodiffusion technique (Home et al, 1970a ). Each serum was tested in duplicate and where appropriate the control serum was included in the same assay plate to minimize the effects of interplate variation (Thompson, Home, Steele, and Goudie, 1969 A highly significant increase in oc2-macroglobulin is observed in the sera of renal patients with proteinuria compared with sera from controls and renal patients without proteinuria (Table II) . There is a highly significant correlation (p < 0'001) between CX2-macroglobulin concentration and amount of proteinuria ( Fig.) but no such correlation is noted between PAG and proteinuria. In addition there is no correlation between blood urea of creatinine clearance and the levels of oc2-macroglobulin or pregnancy-associated globulin. Total urinary protein G/24hr significant correlation, however, is observed between the amount of proteinuria and PAG or x2-macroglobulin.
Discussion
The striking increase in serum ox2-macroglobulin in the nephrotic syndrome is well known (Schultze and Schwick, 1959; Steines and Mehl, 1966; Housley, 1968) . In our study those patients who had renal disease with associated proteinuria show an increase in serum X2-macroglobulin. In addition there is a highly significant correlation between oX2-macroglobulin levels and the degree of proteinuria, a finding which does not appear to have been reported previously. Inspection of the Figure  seems to indicate a proportional rather than a stepwise relationship between the amount of proteinuria and serum x2-macroglobulin and it would appear that raised x2-macroglobulin levels are not peculiar to the nephrotic syndrome. Although the reasons for the raised M2-macroglobulin levels are not clearly understood it would seem unlikely that marked increases in x2-macroglobulin could be attributed to non-specific factors such as diminution in plasma volume.
As anticipated there is an increase in serum PAG levels in patients with renal disease and associated proteinuria. Except for one case, however, the levels of PAG are low in comparison to those found in normal pregnancy. That PAG is demonstrable in the serum more often in renal disease than in other hospital patients lends support to the suggestion that this macroglobulin may be present in all human sera but in such minute quantities that its presence is difficult to detect using conventional immunodiffusion techniques (Maclaren et al, 1966) . Our failure to demonstrate a correlation between PAG and the amount of proteinuria may be due to the unsuitability of our radial immunodiffusion technique for the accurate measurement of very low levels of pregnancy-associated globulin.
In a previous study (Horne et al, 1970a) we demonstrated significantly lower o2-macroglobulin levels in 13 patients with preeclampsia unaccompanied by proteinuria compared with those in normal pregnancy but in the present study we have failed to confirm this finding in an extended group of 26 patients. The raised a2-macroglobulin levels in preeclampsia with proteinuria have been described in our previous study (Home et al, 1970a) . In preeclampsia we have found no coirelation between xC2-macroglobulin and the amount of proteinuria. The low serum PAG levels in preeclampsia unaccompanied by proteinuria are of interest and could be the result of decreased production of oestrogen and/or progestogen which are thought to occur in this disease (Klopper, 1968) , particularly since it has been clearly shown that the levels of this protein increase following the administration of combined oestrogen/progestogen oral contraceptives (Maclaren et al, 1966) . Unlike Ox2-macroglobulin serum PAG levels do not increase in preeclampsia with proteinuria.
Although both pregnancy and the administration of oestrogen/progestogen oral contraceptives result Serum oc-macroglobulins in renal disease and preeclampsia in raised serum levels of x2-macroglobulin (Horne, Howie, Weir, and Goudie, 1970b) and PAG, it is clear that in renal disease and preeclampsia these serum oc-macroglobulins behave in a dissimilar fashion.
